Who Paid My Doc
Daniel Friedmann
Procedural Dermatology Austin, TX Medical Doctor
NPI 1326200569 CMS profile 15451
8825 Bee Caves Rd Ste 100, Austin, TX 78746
General payments
$146,385
Research payments
$13,190
Ownership & investment interest
$0
Research they led as principal investigator
$2,278,926
Through program year 2025, Daniel Friedmann of Austin, TX is reported in the CMS Open Payments database as having received $146,385 across 254 general payments and $13,190 in research payments paid to them. Separately, studies naming them as principal investigator received $2,278,926 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 93rd percentile of Procedural Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
10 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $10,318 | 35 | |
| 2024 | General | $6,402 | 30 | |
| 2024 | Research | $76 | 1 | |
| 2023 | General | $17,091 | 56 | |
| 2022 | General | $38,802 | 37 | |
| 2021 | General | $6,845 | 13 | |
| 2021 | Research | $3,502 | 7 | |
| 2020 | General | $10,944 | 9 | |
| 2019 | General | $55,984 | 74 | |
| 2019 | Research | $9,612 | 3 |
Beside peers
- Daniel Friedmann
- Procedural Dermatology median
- Middle half of Procedural Dermatology
- National median
In program year 2025, general payments to Daniel Friedmann were reported at $10,318. Among 381 Procedural Dermatology profiles paid that year, the median was $592 and the middle half received between $144 and $1,778.
Show as a table
| Year | Daniel Friedmann | Procedural Dermatology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $55,984 | $454 | $152–$1,260 | $163 |
| 2020 | $10,944 | $243 | $90–$835 | $114 |
| 2021 | $6,845 | $337 | $102–$1,128 | $132 |
| 2022 | $38,802 | $443 | $119–$1,654 | $149 |
| 2023 | $17,091 | $583 | $137–$1,838 | $160 |
| 2024 | $6,402 | $611 | $132–$1,835 | $164 |
| 2025 | $10,318 | $592 | $144–$1,778 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
265 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Procedural Dermatology in Texas
Liet Le
Procedural Dermatology · Kingwood, TX
Jean-Denis Boucher
Procedural Dermatology · Live Oak, TX
Tho Nguyen
Procedural Dermatology · Hurst, TX
Douglas Farris
Procedural Dermatology · Hurst, TX
Robert Ochs
Procedural Dermatology · San Antonio, TX
Farhad Niroomand
Procedural Dermatology · Dallas, TX
Related records
Procedural Dermatology in Texas
Practitioners in the same specialty and state, ranked by reported value.
All Procedural Dermatology
Everyone recorded under this specialty, nationwide.
Doctors in Texas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.